Clinical Trials Insight: 700037566
Phase of Trial: Phase II
Latest Information Update: 09 Oct 2009
At a glance
- Drugs Encaleret (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- Sponsors Japan Tobacco; Merck & Co
- 09 Oct 2009 Status changed from not stated to completed.
- 11 Sep 2009 Results have been presented at the 31st Annual Meeting of the American Society for Bone and Mineral Research.
- 30 Sep 2008 New trial record.